Etoposide induces cell death via mitochondrial-dependent actions of p53

Area of Science:

• Cell Biology
• Molecular Oncology
• Cancer Therapeutics

Background:

• Etoposide is a widely used chemotherapeutic agent with an incompletely understood mechanism of action.
• Understanding etoposide's precise role in inducing cell death is crucial for optimizing cancer treatment strategies.

Purpose of the Study:

• To elucidate the specific mechanisms by which etoposide induces cell death in mouse embryonic fibroblasts (MEFs).
• To differentiate between the roles of p53's transcriptional and non-transcriptional functions in etoposide's cytotoxic effects.

Main Methods:

• MEFs were treated with varying concentrations of etoposide to observe cellular responses.
• Investigated both the transcriptional and non-transcriptional activities of p53.
• Utilized p53 inhibitors (Pifithrin-α) and mitochondrial pathway inhibitors (PES) to dissect the cellular pathways involved.

Main Results:

• Higher etoposide concentrations induced apoptosis and activated transcription-dependent p53 functions.
• Lower etoposide concentrations also induced apoptosis, but independently of p53 transcriptional activation.
• Inhibition of p53 transcriptional activity did not prevent etoposide-induced apoptosis.
• Inhibition of the mitochondrial p53 pathway with PES blocked etoposide-induced cell death at all tested concentrations.

Conclusions:

• The transcriptional functions of p53 are not essential for etoposide-induced cell death.
• Etoposide's effects on cell death are primarily mediated by p53's mitochondrial pathway, potentially involving interactions with BCL-2 family members.